Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1962 1
1978 1
1986 1
1988 1
1991 1
1992 1
1995 1
1996 6
1997 3
1998 5
2000 1
2001 2
2002 4
2003 5
2004 2
2005 3
2006 4
2007 5
2008 2
2009 5
2010 2
2011 7
2012 7
2013 10
2014 7
2015 8
2016 8
2017 2
2018 1
2019 3
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ. Xu CX, et al. Among authors: lancaster jm. J Biol Chem. 2016 Oct 21;291(43):22851. doi: 10.1074/jbc.A112.374611. J Biol Chem. 2016. PMID: 27825089 Free PMC article. No abstract available.
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR. Bild AH, et al. Among authors: lancaster jm. Nature. 2006 Jan 19;439(7074):353-7. doi: 10.1038/nature04296. Epub 2005 Nov 6. Nature. 2006. PMID: 16273092
Letter to the Editor.
Hannouf MB, Muzzey D, Kronenwett R, Lancaster JM. Hannouf MB, et al. Among authors: lancaster jm. J Comp Eff Res. 2019 Nov;8(15):1257-1259. doi: 10.2217/cer-2019-0050. Epub 2019 Nov 19. J Comp Eff Res. 2019. PMID: 31741394 Free article. No abstract available.
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Boac BM, Abbasi F, Ismail-Khan R, Xiong Y, Siddique A, Park H, Han M, Saeed-Vafa D, Soliman H, Henry B, Pena MJ, McClung EC, Robertson SE, Todd SL, Lopez A, Sun W, Apuri S, Lancaster JM, Berglund AE, Magliocco AM, Marchion DC. Boac BM, et al. Among authors: lancaster jm. Sci Rep. 2019 Nov 25;9(1):17496. doi: 10.1038/s41598-019-53695-0. Sci Rep. 2019. PMID: 31767884 Free PMC article.
Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Filipits M, Dubsky P, Rudas M, Greil R, Balic M, Bago-Horvath Z, Singer CF, Hlauschek D, Brown K, Bernhisel R, Kronenwett R, Lancaster JM, Fitzal F, Gnant M. Filipits M, et al. Among authors: lancaster jm. Clin Cancer Res. 2019 Jul 1;25(13):3865-3872. doi: 10.1158/1078-0432.CCR-19-0376. Epub 2019 May 7. Clin Cancer Res. 2019. PMID: 31064782 Free article.
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Soliman H, Wagner S, Flake DD 2nd, Robson M, Schwartzberg L, Sharma P, Magliocco A, Kronenwett R, Lancaster JM, Lanchbury JS, Gutin A, Gradishar W. Soliman H, et al. Among authors: lancaster jm. Ann Surg Oncol. 2020 Mar;27(3):765-771. doi: 10.1245/s10434-019-08039-7. Epub 2020 Jan 6. Ann Surg Oncol. 2020. PMID: 31907749 Free PMC article.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page